Enable AccessibilityEnable Accessibility

Takeda Pharmaceuticals North America Expands Sales Organization To Include Medical Center Sales Force

March 13, 2003

LINCOLNSHIRE, IL, March 13, 2003 - Takeda Pharmaceuticals North America, Inc. (TPNA) has expanded its sales organization to form the company's new medical center sales force. The new sales organization consists of approximately 50 medical center sales representatives and managers. TPNA selected the medical center sales representatives from among their existing field sales force and hired additional field sales representatives to backfill their positions.

TPNA's field sales representatives serve patients, physicians and healthcare providers in an office setting, while medical center representatives focus on teaching institutions. TPNA is concentrating on selected medical centers across the country, based on their teaching emphasis - especially those training endocrinology fellows.

"Takeda Pharmaceuticals North America's addition of a medical center sales force is a strategic investment in our future," said Dean Hart, senior vice president of sales for Takeda Pharmaceuticals North America. "It is important for TPNA to continue investing in the success of ACTOS®, as well as to develop important relationships in support of future product launches. We are expanding an already successful sales organization and I am pleased to have these experienced TPNA representatives lead us at these key medical centers."

Takeda Pharmaceuticals North America, Inc.
Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly-owned subsidiary of Takeda Chemical Industries, Ltd. in Osaka, Japan. Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the industry's leaders worldwide, Takeda is committed to strive toward better health for individuals and progress in medicine by developing superior pharmaceutical products.


Angela Bechan
Takeda Pharmaceuticals North America, Inc.

# # #